Type I interferons mediate pancreatic toxicities of PERK inhibition
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type I interferons mediate pancreatic toxicities of PERK inhibition
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 50, Pages 15420-15425
Publisher
Proceedings of the National Academy of Sciences
Online
2015-12-02
DOI
10.1073/pnas.1516362112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The molecular basis for functional plasticity in type I interferon signaling
- (2015) Gideon Schreiber et al. TRENDS IN IMMUNOLOGY
- Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity
- (2015) M Halliday et al. Cell Death & Disease
- PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation
- (2015) Xu Hou et al. Scientific Reports
- Pancreatic Endoplasmic Reticulum Kinase Activation Promotes Medulloblastoma Cell Migration and Invasion through Induction of Vascular Endothelial Growth Factor A
- (2015) Stephanie Jamison et al. PLoS One
- Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
- (2014) S. Bhattacharya et al. EMBO Molecular Medicine
- Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
- (2014) Xiao-Hong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- VEGF Signals through ATF6 and PERK to Promote Endothelial Cell Survival and Angiogenesis in the Absence of ER Stress
- (2014) Evdoxia Karali et al. MOLECULAR CELL
- Druggable sensors of the unfolded protein response
- (2014) Dustin J Maly et al. Nature Chemical Biology
- A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
- (2013) Brandon W Higgs et al. ANNALS OF THE RHEUMATIC DISEASES
- PERK-ing up autophagy during MYC-induced tumorigenesis
- (2013) Souvik Dey et al. Autophagy
- Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
- (2013) C. Atkins et al. CANCER RESEARCH
- Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
- (2013) J. A. Moreno et al. Science Translational Medicine
- Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
- (2013) Jeffrey M. Axten et al. ACS Medicinal Chemistry Letters
- Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study
- (2012) Jacqueline M. McBride et al. ARTHRITIS AND RHEUMATISM
- Abstract 5396: Interferon-α receptor dependent and independent inhibition of type I interferon production in plasmacytoid dendritic cells from mice and melanoma patients
- (2012) Xue-Fei Huang et al. CANCER RESEARCH
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
- (2012) Jacob Piehler et al. IMMUNOLOGICAL REVIEWS
- Uncoupling Proteostasis and Developmentin Vitrowith a Small Molecule Inhibitor of the Pancreatic Endoplasmic Reticulum Kinase, PERK
- (2012) Heather P. Harding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
- (2012) Lori S. Hart et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- (2012) Jeffrey M. Axten et al. JOURNAL OF MEDICINAL CHEMISTRY
- PERK Is Required in the Adult Pancreas and Is Essential for Maintenance of Glucose Homeostasis
- (2012) Y. Gao et al. MOLECULAR AND CELLULAR BIOLOGY
- miR-211 Is a Prosurvival MicroRNA that Regulates chop Expression in a PERK-Dependent Manner
- (2012) Nilesh S. Chitnis et al. MOLECULAR CELL
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses
- (2012) S Bhattacharya et al. ONCOGENE
- The role of interferon alpha in initiation of type I diabetes in the NOD mouse
- (2011) Qing Li et al. CLINICAL IMMUNOLOGY
- The Cell Biology of the Unfolded Protein Response
- (2011) J. Alan Diehl et al. GASTROENTEROLOGY
- Role of p38 Protein Kinase in the Ligand-independent Ubiquitination and Down-regulation of the IFNAR1 Chain of Type I Interferon Receptor
- (2011) Sabyasachi Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in β-cells
- (2010) R. J. Kaufman et al. DIABETES OBESITY & METABOLISM
- Type I interferon: friend or foe?
- (2010) Giorgio Trinchieri JOURNAL OF EXPERIMENTAL MEDICINE
- PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
- (2010) E Bobrovnikova-Marjon et al. ONCOGENE
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Wolcott-Rallison syndrome
- (2010) Cécile Julier et al. Orphanet Journal of Rare Diseases
- PERK in beta cell biology and insulin biogenesis
- (2010) Douglas R. Cavener et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation
- (2009) Daorong Feng et al. BMC CELL BIOLOGY
- Virus-Induced Unfolded Protein Response Attenuates Antiviral Defenses via Phosphorylation-Dependent Degradation of the Type I Interferon Receptor
- (2009) Jianghuai Liu et al. Cell Host & Microbe
- Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon Receptor
- (2009) Sabyasachi Bhattacharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mammalian Casein Kinase 1 and Its Leishmanial Ortholog Regulate Stability of IFNAR1 and Type I Interferon Signaling
- (2009) J. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice
- (2009) Sounak Gupta et al. PLoS One
- Ligand-independent pathway that controls stability of interferon alpha receptor
- (2008) Jianghuai Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interferon- initiates type 1 diabetes in nonobese diabetic mice
- (2008) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started